Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 4731-4740 Newer>

Managed Care March 2008	Drug Caps Lower Spending, but .... These policies tend to make consumers shoulder some of the cost of prescriptions and the cost could be a barrier to medication adherence.
Managed Care March 2008	New Drug Abuse Codes Adopted The American Medical Association says that new CPT codes it developed should make it easier for health plans to determine whether doctors have screened for drug abuse.
Managed Care March 2008 Tony Berberabe	Headlines On Deadline ... The Cleveland Clinic has joined with the Internet giant Google to test a secure exchange of patient medical record data involving prescriptions, conditions, and allergies.
Managed Care March 2008 Martin Sipkoff	PBMs' Rebate Income Threatened By Lawsuits and Move to Generics A recent court settlement may affect the way the PBM industry makes profits, but could it also lead to higher drug costs?
Managed Care March 2008	CMS Hybrid Payment System Shows Promise Combining Medicare fee-for-service payments with new incentive programs could help physician groups save money for Medicare and reach quality-of-care targets.
Managed Care March 2008	PDP Drug Restrictions Block Comparison Shopping A review of 169 commonly used drugs covered by Medicare Prescription Drug Plans (PDPs) reveals that only 4 of the 10 largest plans by enrollment have all of those 169 drugs on formulary.
Managed Care March 2008	Specialty Drug Spending to Double by 2010 Additional indications for existing products, rather than new products, account for the bulk of increased specialty drug use.
The Motley Fool April 4, 2008 Brian Lawler	A Few Thoughts on Dendreon Let's talk about the upcoming Dendreon study results.
The Motley Fool April 4, 2008 Brian Orelli	Why Is Schering Cutting Now? The latest pharmaceutical company to jump on the cost-cutting bandwagon is Schering-Plough.
Chemistry World April 3, 2008 Rebecca Trager	GSK Challenge to US Patent Rules Successful A US district court has said that the US patent office cannot introduce new rules that drug firms argued were a threat to innovation.
<Older 4731-4740 Newer> Return to current articles.